背景:在年轻成年期发展癌症是一种非规范性生活事件,与不良身体相关,社会和心理后果。高心理困扰在AYA癌症患者中很常见,包括焦虑,抑郁或害怕复发。同时,众所周知,AYA经常报告未满足的支持需求,特别是在信息交流和同龄人的情感支持方面,以便从分享的经验中受益并提高自我效能感。尤其是在AYA组,与其他同龄癌症患者的互动可能是应对疾病的重要资源,因为家人和朋友经常不知所措,在无助中挣扎。目前,缺乏使用同伴支持的专业支持服务(例如,心理肿瘤支持,善后咨询,社会法律咨询)或评估德国的同伴支持干预措施。我们的目标是评估Peer2Me干预对AYAs的有效性,其中急性患者(受训者)由AYA幸存者(导师)陪伴三个月。
方法:将使用具有重复措施的前瞻性综合队列设计来评估Peer2Me对AYA的有效性。将纳入180名年龄在18至39岁的积极癌症治疗患者的样本,并将其随机分配到干预或控制条件(单个AYA特异性咨询)。在导师培训之后,学员和导师通过诊断相匹配,年龄,和性别。主要结果是自我效能感;次要结果包括焦虑,抑郁症,健康素养,生活满意度和社会支持生活。结果将在干预前的基线测量(t1),在完成3个月干预后立即(t2)和完成干预后3个月(t3)。对于最终分析,我们将使用意向治疗方法(ITT),并比较指定治疗组中的患者.
结论:Peer2Me可能是年轻癌症患者现有专业社会心理支持服务的重要补充。在研究结束时,应该对接受急性治疗的年轻癌症患者进行心理肿瘤干预,导师和受训者都可以从中受益。应通过与不同合作伙伴的合作确保Peer2Me的长期连续性。
背景:该研究于2022年2月4日在clinicaltrials.gov(NCT05336318)进行了回顾性注册。
BACKGROUND: Developing cancer in young adulthood is a non-normative life event and associated with adverse physical, social and psychological consequences. High psychological distress is common in AYA cancer patients including anxiety, depression or fear of recurrence. At the same time, it is well known that AYA often report unmet needs for support, particularly in terms of informational exchange and emotional support from peers in order to benefit from shared experiences and enhance self-efficacy. Especially in the AYA group, interactions with other same-aged cancer patients may represent an essential resource in terms of coping with the disease, as family members and friends are often overwhelmed and struggling with helplessness. Currently, there is a lack of professional support services using peer support (e.g. psycho-oncological support, aftercare consultations, social legal counselling) or evaluated peer support interventions in Germany. Our aim is to assess the effectiveness of the Peer2Me intervention for AYAs, in which acute patients (mentees) are accompanied by an AYA survivor (mentor) over a period of three months.
METHODS: A prospective Comprehensive Cohort Design with repeated measures will be used to evaluate the effectiveness of Peer2Me for AYA. A sample of 180 patients in active cancer treatment aged 18 to 39 years will be enrolled and randomized to the intervention or control condition (a single AYA-specific consultation). Following mentor training, mentees and mentors are matched by diagnosis, age, and gender. The primary outcome is self-efficacy; secondary outcomes include measures of anxiety, depression, health literacy, life satisfaction and social support life. Outcomes will be measured at baseline before the intervention (t1), immediately after completion of the three-month intervention (t2) and three months after completion the intervention (t3). For the final analyses, we will use an intention-to-treat approach (ITT) and compare patients in the assigned treatment groups.
CONCLUSIONS: Peer2Me might be an important addition to existing professional psychosocial support services for young cancer patients. At the end of the study, a psycho-oncological intervention for young cancer patients undergoing acute treatment should be available, from which both mentors and mentees could benefit. The long-term continuity of Peer2Me should be ensured through collaboration with different partners.
BACKGROUND: The study was retrospectively registered on February 4, 2022 at clinicaltrials.gov (NCT05336318).